Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers

Name: Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers
License: Public Domain

SignalChem Lifesciences Corporation · clinicaltrials

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

lungcancer

lung cancer, nonsmall cell, lung cancer stage iv, lung cancer metastatic

ClinicalTrials.gov Show glossary Search for terms Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.

Record · ID 121340 · SHA-256 e5bfa50054351e7a
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.